Alert detail

LCD L38647: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer — Noridian

Policy ID: LCD-L38647Specialty: UrologyAdded: 6/5/2026Effective: April 16, 2026lcd
Routine

What changed

New MolDX may change bladder cancer billing practices.

Who’s affected: Urology billing teams · Effective: April 16, 2026

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 6 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Urology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Urology audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Urology— the week’s changes and deadlines, delivered to your inbox. No account required.